Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Receivables - Accured (2020 - 2023)

Historic Receivables - Accured for Silo Pharma (SILO) over the last 5 years, with Q3 2023 value amounting to $9600.0.

  • Silo Pharma's Receivables - Accured rose 10000.0% to $9600.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $9600.0, marking a year-over-year increase of 10000.0%. This contributed to the annual value of $6010.0 for FY2022, which is 243.51% down from last year.
  • As of Q3 2023, Silo Pharma's Receivables - Accured stood at $9600.0, which was up 10000.0% from $8390.0 recorded in Q2 2023.
  • Silo Pharma's 5-year Revenue - Other high stood at $85733.0 for Q1 2022, and its period low was $3000.0 during Q2 2020.
  • Moreover, its 4-year median value for Receivables - Accured was $6160.0 (2021), whereas its average is $8445.9.
  • Its Receivables - Accured has fluctuated over the past 5 years, first tumbled by 7790.21% in 2021, then soared by 20045.95% in 2023.
  • Silo Pharma's Receivables - Accured (Quarter) stood at $27876.0 in 2020, then tumbled by 77.9% to $6160.0 in 2021, then dropped by 2.44% to $6010.0 in 2022, then soared by 59.73% to $9600.0 in 2023.
  • Its last three reported values are $9600.0 in Q3 2023, $8390.0 for Q2 2023, and $7193.0 during Q1 2023.